<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Glatiramer acetate</title><link>https://peptidescanner.com/peptides/glatiramer-acetate/</link><description>Versioned, source-linked PeptideScanner evidence objects for Glatiramer acetate. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/glatiramer-acetate.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT05344469</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05344469-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05344469-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct05344469-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-11-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-17</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA090218</title><link>https://peptidescanner.com/stories/fda-drugs-anda090218/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda090218:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda090218-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2015-04-16. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA091646</title><link>https://peptidescanner.com/stories/fda-drugs-anda091646/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda091646:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda091646-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2017-10-03. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA203857</title><link>https://peptidescanner.com/stories/fda-drugs-anda203857/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda203857:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda203857-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2024-09-25. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA206873</title><link>https://peptidescanner.com/stories/fda-drugs-anda206873/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda206873:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda206873-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2024-09-25. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA206921</title><link>https://peptidescanner.com/stories/fda-drugs-anda206921/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda206921:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda206921-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2018-02-12. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA206936</title><link>https://peptidescanner.com/stories/fda-drugs-anda206936/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda206936:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda206936-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2017-10-03. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA208468</title><link>https://peptidescanner.com/stories/fda-drugs-anda208468/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda208468:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda208468-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2025-05-07. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA213382</title><link>https://peptidescanner.com/stories/fda-drugs-anda213382/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda213382:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda213382-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2026-02-11. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA214022</title><link>https://peptidescanner.com/stories/fda-drugs-anda214022/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda214022:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda214022-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2026-02-11. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application ANDA214741</title><link>https://peptidescanner.com/stories/fda-drugs-anda214741/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-anda214741:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-anda214741-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2025-12-31. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA020622</title><link>https://peptidescanner.com/stories/fda-drugs-nda020622/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda020622:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#fda-drugs-nda020622-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 1996-12-20. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register proposed rule 2015-32246</title><link>https://peptidescanner.com/stories/federal-register-2015-32246/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2015-32246:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#federal-register-2015-32246-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2015-12-23. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2016-08682</title><link>https://peptidescanner.com/stories/federal-register-2016-08682/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2016-08682:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#federal-register-2016-08682-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2016-04-15. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2018-15735</title><link>https://peptidescanner.com/stories/federal-register-2018-15735/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2018-15735:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#federal-register-2018-15735-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2018-07-23. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00078338</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00078338-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00078338-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00078338-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-06-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00176592</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00176592-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00176592-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00176592-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-11-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00203021</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00203021-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00203021-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00203021-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-02-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00211887</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00211887-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00211887-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00211887-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2014-04-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00239993</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00239993-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00239993-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00239993-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-02-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00337779</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00337779-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00337779-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00337779-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2011-10-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00451204</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00451204-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00451204-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00451204-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-06-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00451451</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00451451-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00451451-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00451451-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-01-26. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00475865</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00475865-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00475865-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00475865-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-11-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00666224</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00666224-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00666224-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00666224-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-06-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00811395</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00811395-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00811395-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00811395-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-12-31. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00856635</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00856635-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00856635-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00856635-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-02-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00937157</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00937157-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00937157-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00937157-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-03-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00947752</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00947752-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00947752-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct00947752-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-03-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01067521</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01067521-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01067521-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01067521-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-12-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01071083</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01071083-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01071083-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01071083-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-09-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01167426</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01167426-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01167426-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01167426-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-10-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01216072</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01216072-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01216072-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01216072-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2014-02-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01317004</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01317004-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01317004-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01317004-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-06-22. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01534182</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01534182-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01534182-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01534182-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2014-08-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01569451</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01569451-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01569451-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01569451-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-06-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01874145</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01874145-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01874145-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct01874145-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-01-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02153723</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02153723-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02153723-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct02153723-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-11-05. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02499900</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02499900-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02499900-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct02499900-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-12-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03193866</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03193866-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03193866-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#clinicaltrials-gov-nct03193866-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-04-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22449210-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22449210-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-22449210-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2015-11-19. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22989378-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22989378-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-22989378-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-04-08. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?</title><link>https://peptidescanner.com/stories/pubmed-pmid-23203082-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23203082-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23203082-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-05-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Interferon beta and glatiramer acetate therapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23264098-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23264098-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23264098-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-02-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Randomized study combining interferon and glatiramer acetate in multiple sclerosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23424159-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23424159-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23424159-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-05-18. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23589190-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23589190-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23589190-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-10-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The use of interferon Beta and glatiramer acetate in multiple sclerosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23709209-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23709209-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23709209-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2015-11-19. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23795716-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23795716-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-23795716-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-04-08. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-25062935-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-25062935-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-25062935-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Spasticity in multiple sclerosis and role of glatiramer acetate treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26445705-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26445705-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-26445705-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-11-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26458034-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26458034-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-26458034-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).</title><link>https://peptidescanner.com/stories/pubmed-pmid-26671082-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26671082-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-26671082-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2015-12-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Pharmacologic Treatment of Rett Syndrome With Glatiramer Acetate.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27363291-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27363291-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-27363291-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-05-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27473139-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27473139-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-27473139-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-11-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27880972-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27880972-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-27880972-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-09-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Equivalence of glatiramer acetate products: challenges in assessing pharmaceutical equivalence and critical clinical performance attributes.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29241378-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29241378-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-29241378-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-07-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30775037-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30775037-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-30775037-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-09-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Glatiramer acetate: A complex drug beyond biologics.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30902653-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30902653-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-30902653-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-08-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Glatiramer Acetate: from Bench to Bed and Back.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30905097-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30905097-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-30905097-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-04-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Comparison of Copaxone® and Synthon&apos;s therapeutically equivalent glatiramer acetate.</title><link>https://peptidescanner.com/stories/pubmed-pmid-31526436-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-31526436-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-31526436-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-06-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32897569-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32897569-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-32897569-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-01-19. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Treatment Challenges in Multiple Sclerosis - A Continued Role for Glatiramer Acetate?</title><link>https://peptidescanner.com/stories/pubmed-pmid-35493825-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35493825-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-35493825-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-07-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35563884-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35563884-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-35563884-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39406508-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39406508-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-39406508-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-05-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41705515-glatiramer-acetate/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41705515-glatiramer-acetate:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/glatiramer-acetate.json#pubmed-pmid-41705515-glatiramer-acetate-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-07-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
